Assessing the Transformational Phase of the Diflunisal Market
The evolving pharmaceutical ecosystem has led to growing interest in anti-inflammatory therapies, particularly in regions where chronic pain and arthritis conditions continue to rise. Diflunisal, a nonsteroidal anti-inflammatory drug used for pain relief and inflammation management, remains an important component of this therapeutic class. Increasing healthcare awareness, expanding access to...